In contrast, β-actin promoter-driven SRG3 overexpression attenuated the severity of MBP-induced EAE and reduced the clinical symptoms of LPS/D-GalN-induced sepsis via alternative macrophage activation [5,6]. Here, SMARCC1 is linked to Sepsis.